Evidence map›Paper›PMID 28281038›Full record

ArticleVeterinary research communications2017

Effect of intramammary infusion of recombinant bovine GM-CSF and IL-8 on CMT score, somatic cell count, and milk mononuclear cell populations in Holstein cows with Staphylococcus aureus subclinical mastitis.

Yoshio Kiku, Tomomi Ozawa, Hideyuki Takahashi, Shiro Kushibiki, Shigeki Inumaru, Hiroyuki Shingu, Yuya Nagasawa, Atsushi Watanabe, Eiji Hata, Tomohito Hayashi

Abstract read
PubMed Publisher
In one paragraph

Article in Veterinary research communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yoshio KikuHokkaido Research Station, National Institute of Animal Health, NARO, 4 Hitsujigaoka, Toyohira, Sapporo, Hokkaido, 062-0045, Japan.
Tomomi OzawaNational Institute of Animal Health, NARO, Tsukuba, Ibaraki, 305-0856, Japan.
Hideyuki TakahashiNational Institute of Animal Health, NARO, Tsukuba, Ibaraki, 305-0856, Japan.
Shiro KushibikiNARO Institute of Livestock and Grassland Science, Tsukuba, Ibaraki, 305-0901, Japan.
Shigeki InumaruNational Institute of Animal Health, NARO, Tsukuba, Ibaraki, 305-0856, Japan.
Hiroyuki ShinguNARO Institute of Livestock and Grassland Science, Tsukuba, Ibaraki, 305-0901, Japan.
Yuya NagasawaHokkaido Research Station, National Institute of Animal Health, NARO, 4 Hitsujigaoka, Toyohira, Sapporo, Hokkaido, 062-0045, Japan.
Atsushi WatanabeHokkaido Research Station, National Institute of Animal Health, NARO, 4 Hitsujigaoka, Toyohira, Sapporo, Hokkaido, 062-0045, Japan.
Eiji HataHokkaido Research Station, National Institute of Animal Health, NARO, 4 Hitsujigaoka, Toyohira, Sapporo, Hokkaido, 062-0045, Japan.
Tomohito HayashiHokkaido Research Station, National Institute of Animal Health, NARO, 4 Hitsujigaoka, Toyohira, Sapporo, Hokkaido, 062-0045, Japan. hayatomo@affrc.go.jp.
National Institute of Animal Health · JPInstitute of Livestock and Grassland Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effect of intramammary infusion of recombinant bovine granulocyte-macrophage colony-stimulating factor (rbGM-CSF) and interleukin-8 (rbIL-8) on mononuclear cell populations in quarters, somatic cell count (SCC) and the California Mastitis Test (CMT) score were investigated. From the selected cows with naturally occurring Staphylococcus aureus subclinical mastitis, one quarter of each cow were selected for the infusions of rbGM-CSF (400 μg/5 mL/quarter, n = 9), rbIL-8 (1 mg/5 mL/quarter, n = 9), and phosphate-buffered saline (5 mL/quarter, n = 7). The CMT score of both cytokines post infusion temporarily increased between days 0 and 1 and significantly decreased between days 7 and 14 compared to the preinfusion level. The SCC on day 14 after infusions of rbGM-CSF tended to be lower than that of the control group. The percentage of CD14+ cells increased on days 1 and 2 post infusion of rbGM-CSF. The percentage of CD4+ and CD8+ cells also increased on days 2 and 3, suggesting that the infusion of rbGM-CSF enhanced cellular immunity in the mammary gland. In contrast, the percentage of CD14+ cells decreased on days 0.25 and 1 post infusion of rbIL-8. No significant changes in the percentages of CD4+ and CD8+ cells in milk after infusion of rbIL-8 were evident during the experimental period, which suggested that rbIL-8 had little effect on the function of T cells in the mammary gland. These results indicated that rbGM-CSF and rbIL-8 decreased the CMT score by a different mechanism and may have a potential as therapeutic agents for subclinical mastitis.

Indexed as

AnimalsAsymptomatic InfectionsCattleCell CountFemaleFlow CytometryGranulocyte-Macrophage Colony-Stimulating FactorInterleukin-8Leukocyte CountMammary Glands, AnimalMastitis, BovineRecombinant ProteinsStaphylococcal InfectionsGranulocyte-Macrophage Colony-Stimulating FactorInterleukin-8Recombinant ProteinsBovineCMTGM-CSFIL-8MastitisMilk mononuclear cell population

Identifiers

PMID28281038
OpenAlexW2594176572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.